Ropes and Gray: Alentis and PinotBio Announce Collaboration to Develop Next-Generation ADCs Targeting Claudin-1
October 15, 2026
October 15, 2026
BOSTON, Massachusetts, Oct. 15 -- Ropes and Gray, a law firm, issued the following news:
* * *
Alentis and PinotBio Announce Collaboration to Develop Next-Generation ADCs Targeting claudin-1
October 14, 2026
Ropes & Gray represented Alentis Therapeutics in a research collaboration and licensing agreement with PinotBio to discover and develop next-generation antibody-drug conjugates (ADCs) to expand the potential of claudin-1 as a therapeuti . . .
* * *
Alentis and PinotBio Announce Collaboration to Develop Next-Generation ADCs Targeting claudin-1
October 14, 2026
Ropes & Gray represented Alentis Therapeutics in a research collaboration and licensing agreement with PinotBio to discover and develop next-generation antibody-drug conjugates (ADCs) to expand the potential of claudin-1 as a therapeuti . . .